A Multicenter, Post-Market Clinical Follow-up Study of Subjects With the REDAPT™ System Monolithic Sleeveless/Sleeved Stem and/or Fully Porous Acetabular Shell With XLPE Liner and/or Modular Shell Components Previously Implanted
← catalyst calendarNCT03610789 · readout in 2,873 d
Sponsored by Smith & Nephew, Inc. (industry) · SNN — their whole pipeline →.
Phase
—
Status
Enrolling by invitation
Study type
Observational
Enrollment
220estimated
Sites
4
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2018-05-07 | actual | When the study began enrolling |
| Primary completion | 2034-07-01 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2034-07-01 | estimated | The whole study's end, after follow-up |
| First posted | 2018-08-01 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-01-06 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Hip Replacement
Intervention
- Device: REDAPT
Primary outcome
what the primary-completion date above is the date OFRevision rate
measured 10 years post-op
Permalink · SNN's whole pipeline · Catalyst calendar · Every registered study · What changed